Developing new neuropsychotropic drugs--focus on hypnotics.
D001143:Arousal / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects / Q000627:therapeutic use*; D018377:Neurotransmitter Agents / Q000378:metabolism; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*; D012894:Sleep Stages / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000209:etiology
D006993:Hypnotics and Sedatives; D018377:Neurotransmitter Agents